These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 14718896

  • 61. Revascularization of left anterior descending artery with drug-eluting stents: comparison with off-pump surgery.
    Herz I, Moshkovitz Y, Hendler A, Adam SZ, Uretzky G, Ben-Gal Y, Mohr R.
    Ann Thorac Surg; 2005 Jan; 79(1):88-92. PubMed ID: 15620921
    [Abstract] [Full Text] [Related]

  • 62. Experience with percutaneous transluminal renal angioplasty in renovascular hypertension.
    Pedersen EB, Madsen B, Danielsen H, Jespersen B.
    Acta Med Scand Suppl; 1986 Jan; 714():23-7. PubMed ID: 2953176
    [Abstract] [Full Text] [Related]

  • 63. Results of renal artery revascularization in the post-ASTRAL era with 4 years mean follow-up.
    Zachrisson K, Krupic F, Svensson M, Wigelius A, Jonsson A, Dimopoulou A, Stenborg A, Jensen G, Herlitz H, Gottsäter A, Falkenberg M.
    Blood Press; 2020 Oct; 29(5):285-290. PubMed ID: 32363961
    [Abstract] [Full Text] [Related]

  • 64. [Surgical complications after renal percutaneous transluminal angioplasty].
    Szyber P, Janczak D, Garcarek J, Karasek M.
    Wiad Lek; 1997 Oct; 50 Suppl 1 Pt 2():48-50. PubMed ID: 9424924
    [Abstract] [Full Text] [Related]

  • 65. Renovascular hypertension: results of medical and surgical therapy.
    Whelton PK, Harris AP, Russell RP, Walsh PC, Williams GM, Harrington DP, Walker WG.
    Johns Hopkins Med J; 1981 Dec; 149(6):213-9. PubMed ID: 7311261
    [Abstract] [Full Text] [Related]

  • 66. Preservation of renal function by percutaneous transluminal angioplasty in ischaemic renal disease.
    Paulsen D, Kløw NE, Rogstad B, Leivestad T, Lien B, Vatne K, Fauchald P.
    Nephrol Dial Transplant; 1999 Jun; 14(6):1454-61. PubMed ID: 10383007
    [Abstract] [Full Text] [Related]

  • 67. Renovascular disease in diabetes mellitus: treatment by percutaneous transluminal renal angioplasty.
    Zuccalà A, Losinno F, Zucchelli A, Zucchelli PC.
    Nephrol Dial Transplant; 1998 Jun; 13 Suppl 8():26-9. PubMed ID: 9870422
    [Abstract] [Full Text] [Related]

  • 68. Percutaneous transluminal angioplasty in the treatment of renovascular hypertension: sequential prospective study.
    Miranda Júnior F, Perez Mdel C, Plavnik F, Francisco Júnior J, Burihan E.
    Sao Paulo Med J; 1998 Jun; 116(1):1613-7. PubMed ID: 9699383
    [Abstract] [Full Text] [Related]

  • 69. New techniques for percutaneous renal revascularization: atherectomy and stenting.
    Graor RA.
    Urol Clin North Am; 1994 May; 21(2):245-53. PubMed ID: 8178392
    [Abstract] [Full Text] [Related]

  • 70. Hypertension and renovascular disease: follow-up on 100 renal vein renin samplings.
    Hasbak P, Jensen LT, Ibsen H, East Danish Study Group on Renovascular Hypertension.
    J Hum Hypertens; 2002 Apr; 16(4):275-80. PubMed ID: 11967722
    [Abstract] [Full Text] [Related]

  • 71. Should percutaneous transluminal renal artery angioplasty be applied to ostial renal artery atherosclerosis?
    Eldrup-Jorgensen J, Harvey HR, Sampson LN, Amberson SM, Bredenberg CE.
    J Vasc Surg; 1995 Jun; 21(6):909-14; discussion 914-5. PubMed ID: 7776470
    [Abstract] [Full Text] [Related]

  • 72. Renal vein renin analysis: limitations of its use in predicting benefit from percutaneous angioplasty.
    Martin LG, Cork RD, Wells JO.
    Cardiovasc Intervent Radiol; 1993 Jun; 16(2):76-80. PubMed ID: 8485747
    [Abstract] [Full Text] [Related]

  • 73. Percutaneous renal artery stenting reduces arterial blood pressure, but what about renal function? A single-center experience.
    Dervişoğlu E, Ciftçi E, Selek A, Sarisoy HT, Kalender B, Yilmaz A.
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):61-5. PubMed ID: 20150008
    [Abstract] [Full Text] [Related]

  • 74. Midterm Outcomes of Angioplasty for Pediatric Renovascular Hypertension.
    Zhao L, Zhao X, Hu X, Yang H, Wu L.
    J Vasc Interv Radiol; 2022 Apr; 33(4):399-407. PubMed ID: 34896573
    [Abstract] [Full Text] [Related]

  • 75. [Experience with percutaneous transluminal angioplasty of renal arteries (PTRA)].
    Stríbrná J, Belán A, Veselá M, Horák K.
    Cas Lek Cesk; 1983 Dec 30; 122(52):1616-9. PubMed ID: 6229334
    [No Abstract] [Full Text] [Related]

  • 76. Related factors for worsening renal function following percutaneous transluminal renal angioplasty (PTRA) in patients with atherosclerotic renal artery stenosis.
    Yoshihara F, Fukuda T, Iwashima Y, Nakamura S, Hayashi S, Kishida M, Ishizuka A, Kusunoki H, Ohta Y, Kawano Y.
    Clin Exp Hypertens; 2015 Dec 30; 37(7):526-30. PubMed ID: 25919953
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Invasive treatment for renovascular disease. A twenty year experience from a population based registry.
    Bergqvist D, Björck M, Lundgren F, Troëng T.
    J Cardiovasc Surg (Torino); 2008 Oct 30; 49(5):559-63. PubMed ID: 18670374
    [Abstract] [Full Text] [Related]

  • 79. Outpatient percutaneous transluminal renal artery angioplasty: a Canadian experience.
    Peterson RA, Baldauf CG, Millward SF, Aquino J, Delbrouck N.
    J Vasc Interv Radiol; 2000 Mar 30; 11(3):327-32. PubMed ID: 10735427
    [Abstract] [Full Text] [Related]

  • 80. Efficacy of 24-Hour Blood Pressure Monitoring in Evaluating Response to Percutaneous Transluminal Renal Angioplasty.
    Jujo K, Saito K, Ishida I, Furuki Y, Ouchi T, Kim A, Suzuki Y, Sekiguchi H, Yamaguchi J, Ogawa H, Hagiwara N.
    Circ J; 2016 Aug 25; 80(9):1922-30. PubMed ID: 27439675
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.